Usted buscó: ghan nom u in rappresentanza (Maltés - Inglés)

in-nanoteknoloġiji u in-nanoxjenzi
nano-technologies and nano-sciences

verheugen (intrapri �a u in-
verheugen the

t h e e u in ma jiġux legalment.
e eu in t h not.

trabectedin huwa ġenotossiku kemm in vitro u in vivo.
trabectedin is genotoxic both in vitro and in vivo.

> ħiliet avvanzati, li juru kapaċità u in-
> advanced skills, demonstrating

interazzjonijiet farmakokinetiċi tal-mediċina in vivo u in vitro
in vivo and in vitro pharmacokinetic drug interactions

Ġenituri: samba naualna u in-uasne nanfafe
parentage: samba naualna and in-uasne nanfafe

posaconazole ma kienx ġenotossiku fi studji in vitro u in vivo.
posaconazole was not genotoxic in in vitro and in vivo studies.

mutazzjonijiet batteriċu testijiet tal- mammiferi in vitro u in vivo. i
13 mutagenicity olanzapine was not mutagenic or clastogenic in a full range of standard tests, which included bacterial mutation tests and in vitro and in vivo mammalian tests.

dejta in vitro u in vivo tindika li ivacaftor jiġi metabolizzat primarjament minn cyp3a.
in vitro and in vivo data indicate that ivacaftor is primarily metabolised by cyp3a.

ghan-nom tal-kunsill regolatorju tal-bce willem f. duisenberg
on behalf of the governing council of the ecb willem f. duisenberg

ghan-nom tal-kunsill li jirregola l-bce willem f. duisenberg
on behalf of the governing council of the ecb willem f. duisenberg

simeprevir ma kienx ġenotossiku f’serje ta’ tests in vitro u in vivo.
simeprevir was not genotoxic in a series of in vitro and in vivo tests.

interferon alfa-2b rikombinanti jimpedixxi wkoll replikazzjoni tal-virus in vitro u in vivo.
recombinant interferon alfa-2b also inhibits viral replication in vitro and in vivo.

becaplermin ma’ kienx mutaġeniku f’għadd ta’ testjiet in vitro u in vivo.
becaplermin was not mutagenic in a battery of in vitro and in vivo tests.

ghan-nom tal-kunsill regolatorju tal-bce il-president willem f. duisenberg
on behalf of the governing council of the ecb the president willem f. duisenberg

il-pożizzjoni attwali tal-ugwaljanza u in-nuqqas ta’ diskriminazzjoni fl-ue
current position of equality and non-discrimination in the eu

il-pożizzjoni attwali ta’ l-ugwaljanza u in-nuqqas ta’ diskriminazzjoni fl-ue
current position of equality and non-discrimination in the eu

id-data u in-numru ta’ reġistrazzjoni u d-data tal-pubblikazzjoni tar-reġistrazzjoni;
the date and the registration number and the date of the publication of the registration;

ghar-rigward ta » l-operazzjonijiet kollha maghmula mill-bcni ghan-nom ta » l-bce , kull bcn ghandu jiżvela lill-partijiet kollha l-istatus ta » l-bce bhala principal meta jiftiehem dwar kull operazzjoni , kemm fl-isem u firriferenza ghan-numru tal-kont jew l-identifikatur .
in relation to all operations conducted by the ncbs on behalf of the ecb , each ncb shall disclose to all parties the ecb 's status as principal when agreeing on each operation , both by name and by reference to an account number or identifier .